AstraZeneca’s Chimpanzee Cold Virus Vaccine Against COVID Shows 70% Efficacy

AstraZeneca’s Chimpanzee Cold Virus Vaccine Against COVID Shows 70% Efficacy


Earlier, media reported preliminary results of clinical trials of the coronavirus vaccine being developed by the University of Oxford and the AstraZeneca pharmaceutical company claiming it has shown a sustainable immune reaction to infection among elderly people.

Source link

Leave a comment

Do NOT follow this link or you will be banned from the site!